Credit Suisse Ag Mustang Bio, Inc. Transaction History

Credit Suisse Ag

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.73 - $1.81 $7,387 - $18,317	-10,120 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.66 - $2.64 $16,799 - $26,716	10,120 New	10,120 $17,000
Q1 2021 May 14, 2021	SELL	$3.02 - $5.16 $45,245 - $77,307	-14,982 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$2.66 - $4.18 $39,852 - $62,624	14,982 New	14,982 $57,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $21M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.